Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance

🤔

Gilead’s Covid-19 drug remdesivir will be priced at $3,120 for a typical U.S. patient with commercial insurance.


Gilead Sciences Inc. detailed its pricing plans for Covid-19 drug remdesivir, saying it will charge U.S. hospitals $3,120 for a typical patient with commercial insurance.

The drugmaker on Monday disclosed its pricing plans as it prepares to begin charging for the drug in July. The U.S. has been distributing remdesivir donated by Gilead since the drug was authorized for emergency use in May.

How Chinese tech giants are disrupting insurance industry with pooled funds

However, the situation has been improving as Chinese tech giants including e-commerce company Alibaba, search engine Baidu, on-demand delivery company Meituan Dianping, ride-hailing operator Didi Chuxing and smartphone maker Xiaomi now offer more affordable health care plans via mutual aid platforms, which operate as a collective claim-sharing mechanism.


China’s online mutual aid platforms are disrupting old school insurance companies by leveraging big data and internet finance technologies to offer low cost medical coverage.

Newborn Pluto Was Hot and Had Subsurface Ocean: Study

Pluto is thought to possess a subsurface ocean beneath its thick ice shell. It has generally been assumed that the dwarf planet formed out of cold material and then later developed its ocean due to warming from radioactive decay. By combining numerical simulations with geological observations by NASA’s New Horizons mission, a team of researchers from the University of California Santa Cruz and the Southwest Research Institute demonstrated that Pluto was instead relatively hot when it formed, with an early subsurface ocean.

Canadarm3 to support Lunar Gateway space station

Canada is marching forward with its international partners to establish a permanent research installation near the Moon, the Lunar Gateway.

As it did for the Shuttle and Station programs before, the Canadian Space Agency, via a partnership with MacDonald, Dettwiler, and Associates, Inc., will build the next-generation robotic system: Canadarm3.

This smart robotic system will be Canada’s contribution to the US-led Lunar Gateway station for the Artemis Program, the next major international collaboration in human space exploration — which forms the cornerstone of Canadian space strategy.